Jasper Therapeutics

Jasper Therapeutics JSPR Stock

$11.85   14.603484%
Add to favorites
Market Cap
$13.14M
LOW - HIGH [24H]
$10.66 - $11.86
VOLUME [24H]
$14.12K
P/E Ratio
0
Earnings per share
-$7.41
ISIN
US4718712023
Price   Prediction

Jasper Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Jasper Therapeutics (JSPR) stock price today is 11.85 USD on Tech Market Small (+14.6% on the day). Updated .

Jasper Therapeutics JSPR Financial and Trading Overview

Jasper Therapeutics stock price 11.85 USD
Previous Close 13.68 USD
Open 13.67 USD
Bid 0.41 USD x 200
Ask 14.5 USD x 200
Day's Range 11.77 - 14.35 USD
52 Week Range 9.45 - 72.6 USD
Volume 23.44K USD
Avg. Volume 18.34K USD
Market Cap 13.06M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -7.41 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 600 USD

JSPR Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E -0.7619124
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 235.40001
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Jasper Therapeutics Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -74.52%
S&P500 52-Week Change 13.32%
52 Week High 72.6 USD
52 Week Low 9.45 USD
50-Day Moving Average 16.79 USD
200-Day Moving Average 23.96 USD

JSPR Share Statistics

Avg. Volume (3 month) 18.34K USD
Avg. Daily Volume (10-Days) 35K USD
Shares Outstanding 1.11M
Float N/A
Short Ratio 17.19
% Held by Insiders 2.54%
% Held by Institutions 56.36%
Shares Short 229.08K
Short % of Float 21.26%
Short % of Shares Outstanding 20.64%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:30

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq) N/A
Next Fiscal Year End N/A

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -31.2
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 0.05

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Jasper Therapeutics

Country United States
State CA
City Redwood City
Address 2200 Bridge Pkwy
ZIP 94065
Phone 650-549-1400
Website https://jaspertx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. Its products in various stages of development include KP-104, a dual-complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) which is in Phase 2; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is headquartered in Redwood City, California.

Q&A For Jasper Therapeutics Stock

What is a current JSPR stock price?

Jasper Therapeutics JSPR stock price today per share is 11.85 USD.

How to purchase Jasper Therapeutics stock?

You can buy JSPR shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Jasper Therapeutics?

The stock symbol or ticker of Jasper Therapeutics is JSPR.

Which industry does the Jasper Therapeutics company belong to?

The Jasper Therapeutics industry is Biotechnology.

How many shares does Jasper Therapeutics have in circulation?

The max supply of Jasper Therapeutics shares is 1.11M.

What is Jasper Therapeutics Price to Earnings Ratio (PE Ratio)?

Jasper Therapeutics PE Ratio is now.

What was Jasper Therapeutics earnings per share over the trailing 12 months (TTM)?

Jasper Therapeutics EPS is -7.41 USD over the trailing 12 months.

Which sector does the Jasper Therapeutics company belong to?

The Jasper Therapeutics sector is Healthcare.

Jasper Therapeutics JSPR included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24450.37 USD —
+0.5
5.97B USD — 24225.3 USD — 24538.78 USD — — 5.97B USD —
us US Tech Health Care IXHC US 1324.83 USD —
-0.6
— — 1322.85 USD — 1342.46 USD — — — —
$2.16T
Total marketcap
$71.41B
Total volume
BTC 58.01%   •   ETH 9.87%
Dominance
Select currency